Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no study data or core content appears to be affected.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter updates: the page now displays 'Revision: v3.3.3' and the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' mention were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision label changed from v3.2.0 to v3.3.2, with no other changes to trial details or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding status notice/banner was removed from the page. This does not affect the study data or enrollment details.SummaryDifference0.4%

- Check75 days agoChange DetectedNew screenshot shows a UI redesign with updated layout and visuals, while all trial data (outcome measures, eligibility criteria, study dates, and recruitment status) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded a government-status notice and version v3.2.0; removed the previous version v3.1.0.SummaryDifference7%

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.